Dexketoprofen Ketoflix, 25 mg, coated tablets
Dexketoprofen
This medicine should always be taken as described in this leaflet for the patient or as directed by a doctor or
pharmacist.
Dexketoprofen Ketoflix is a pain-relieving medicine belonging to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
It is used for the symptomatic treatment of mild to moderate pain, such as muscle and bone pain, painful menstruation, toothache.
If after 3-4 days there is no improvement or the patient feels worse, they should consult a doctor.
When not to take Dexketoprofen Ketoflix:
Before taking Dexketoprofen Ketoflix, the patient should discuss it with their doctor or pharmacist:
Dexketoprofen Ketoflix may mask the symptoms of an infection, such as fever and pain. Therefore, Dexketoprofen Ketoflix may delay the use of appropriate infection treatment, which may lead to increased risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If the patient is taking this medicine during an infection and the infection symptoms persist or worsen, they should consult their doctor immediately.
The use of Dexketoprofen Ketoflix in children and adolescents has not been studied. The safety and efficacy of this medicine have not been established, and therefore, it should not be used in children and adolescents.
The patient should tell their doctor or pharmacist about all medicines they are taking, including those available without a prescription, and about any medicines they plan to take.
Some medicines should not be taken with Dexketoprofen Ketoflix, and for others, the dose may need to be changed when taken with Dexketoprofen Ketoflix.
The patient should always inform their doctor, dentist, or pharmacist if they are taking any of the following medicines with Dexketoprofen Ketoflix:
In case of any doubts about taking Dexketoprofen Ketoflix, the patient should consult their doctor or pharmacist.
Dexketoprofen Ketoflix tablets should be swallowed with a sufficient amount of water. Taking the tablets with food can reduce the risk of gastrointestinal side effects.
However, in case of acute pain, it is recommended to take the medicine on an empty stomach (at least 30 minutes before a meal), which will allow for faster onset of action (see "Dexketoprofen Ketoflix with food and drink").
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Dexketoprofen Ketoflix should not be taken if the patient is in the last 3 months of pregnancy, as it may harm the unborn child or cause complications during delivery.
It may cause kidney and heart problems in the unborn child. It may increase the risk of bleeding in the mother and child and cause delayed or prolonged labor. During the first 6 months of pregnancy, Dexketoprofen Ketoflix should not be used unless the doctor considers it absolutely necessary. If treatment is necessary during this period or when trying to conceive, the lowest possible dose should be used for the shortest possible time. From the 20th week of pregnancy, Dexketoprofen Ketoflix may cause kidney problems in the unborn child if taken for more than a few days. This may lead to a decrease in the amount of amniotic fluid surrounding the baby (oligohydramnios). If treatment is necessary for a longer period, the doctor may recommend additional monitoring.
Dexketoprofen Ketoflix should not be used in breastfeeding women.
Dexketoprofen Ketoflix may affect fertility, and its use is not recommended in women with fertility problems, planning pregnancy, or undergoing fertility treatment.
Dexketoprofen Ketoflix may have a minor effect on the ability to drive vehicles and operate machinery due to possible side effects such as dizziness or drowsiness. If such symptoms are observed, the patient should not drive vehicles or operate moving machinery until the symptoms have resolved. In case of doubts, the patient should consult their doctor.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
Dexketoprofen Ketoflix is intended for short-term use only, and treatment should be limited to the period of symptoms.
The patient should use the smallest effective dose for the shortest necessary time.
If the symptoms of an infection (such as fever and pain) persist or worsen, the patient should consult their doctor immediately (see section 2).
The recommended daily dose depends on the type, severity, and duration of the pain, usually 1/2 tablet (12.5 mg) every 4-6 hours or 1 tablet (25 mg) every 8 hours. The total daily dose should not exceed 3 coated tablets (75 mg).
In elderly patients, with kidney or liver disease, it is recommended to start treatment with a lower total daily dose equivalent to no more than 2 coated tablets (50 mg).
In elderly patients with good tolerance, the initial dose can be increased to the recommended dose for the general population (75 mg).
In case of acute pain, when faster action is needed, it is recommended to take Dexketoprofen Ketoflix on an empty stomach (at least 30 minutes before a meal), which will allow for faster absorption of the medicine (see "Dexketoprofen Ketoflix with food and drink").
In case of suspected overdose, the patient should inform their doctor or pharmacist or go to the emergency department of the nearest hospital. The patient should remember to take the medicine packaging or patient leaflet with them.
The patient should not take a double dose to make up for a missed dose. The next dose should be taken according to the dosing schedule (see section 3 "How to take Dexketoprofen Ketoflix").
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Dexketoprofen Ketoflix can cause side effects, although not everybody gets them.
Possible side effects are listed below and are grouped according to their frequency:
Nausea and/or vomiting, stomach pain, diarrhea, indigestion (dyspepsia).
Dizziness, drowsiness, sleep disorders, nervousness, headaches, palpitations, facial flushing, gastrointestinal disorders, constipation, dry mouth, bloating with gas, rash, fatigue, pain, feeling of heat and chills, malaise.
Stomach ulcers, gastrointestinal bleeding, or perforation, which may manifest as bloody vomiting or black stools, fainting, high blood pressure, slowed breathing rate, fluid retention and peripheral edema (e.g., swollen ankles), throat swelling, loss of appetite (anorexia), abnormal sensation, itchy rash, acne, increased sweating, back pain, increased urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute kidney failure.
Anaphylactic reactions (acute hypersensitivity reactions that can lead to anaphylactic shock), skin, lip, eye, and genital ulcers (Stevens-Johnson syndrome and Lyell's syndrome), facial or lip and throat swelling (angioedema), shortness of breath caused by bronchospasm, rapid heart rate, low blood pressure, pancreatitis, blurred vision, tinnitus, skin hypersensitivity reactions, skin hypersensitivity to sunlight, itching, kidney function disorders, decreased white blood cell count (neutropenia), decreased platelet count (thrombocytopenia).
The patient should inform their doctor if they notice any side effects, especially those related to the stomach or intestines (e.g., stomach pain, heartburn, or bleeding), if they have had similar side effects in the past due to long-term use of anti-inflammatory medicines; this is especially important for elderly patients.
If a skin rash or any skin changes or mucosal lesions (e.g., inside the mouth or on the genitals) or any symptoms of allergy occur, the patient should stop taking Dexketoprofen Ketoflix immediately.
During the administration of non-steroidal anti-inflammatory drugs, fluid retention and edema (especially of the ankles and feet) may occur, as well as increased blood pressure and heart failure.
Taking such medicines as Dexketoprofen Ketoflix may be associated with a small increased risk of heart attack or stroke.
In patients with systemic lupus erythematosus or mixed connective tissue disease (immune system disorders affecting connective tissue), the administration of anti-inflammatory medicines may rarely cause fever, headache, and neck stiffness.
If side effects occur, including any side effects not listed in the leaflet, the patient should tell their doctor or pharmacist, or nurse.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
The medicine should not be used after the expiration date stated on the carton and blister.
The expiration date refers to the last day of the month.
Store in a temperature below 25°C.
Store in the original packaging to protect from light.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is dexketoprofen trometamol. 1 coated tablet contains 25 mg of dexketoprofen in the form of 36.90 mg of dexketoprofen trometamol.
Other ingredients are: cornstarch, microcrystalline cellulose, sodium carboxymethylcellulose, glycerol distearate, Opadry Y-1-7000 coating (hypromellose, titanium dioxide (E-171), macrogol 400).
Dexketoprofen Ketoflix is available in the form of white, biconvex, cylindrical coated tablets with a dividing line and engraved with "DT2" on one side. The tablets can be divided into equal doses.
PVC/PVDC/Aluminum blister pack in a cardboard box.
Dexketoprofen Ketoflix is supplied in packs containing: 10, 20, 30, 40, or 50 coated tablets.
Not all pack sizes may be marketed.
Biofarm Sp. z o.o.
Wałbrzyska Street 13
60-198 Poznań
phone: +48 61 66 51 500
fax: +48 61 66 51 505
email: biofarm@biofarm.pl
SAG MANUFACTURING S.L.U.
N-I Road, Km 36
28750 San Agustin de Guadalix, Madrid
Spain
Galenicum Health, S.L.U
Sant Gabriel, 50,
Esplugues de Llobregat
08950 Barcelona
Spain
Date of last revision of the leaflet 25.10.2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.